Client Resource, Recovery
Cortisol is not the enemy. Chronic unresolved stress is. Understanding the difference changes how you manage recovery, training, and health.
Cortisol has become a wellness villain. It is presented as the cause of weight gain, muscle loss, sleep disruption, immune suppression, and accelerated ageing. Much of this is not wrong, but it lacks essential context. Cortisol is a steroid hormone essential for life. It regulates metabolism, immune function, cardiovascular tone, blood glucose, and the body's response to physiological challenge. The problem is not cortisol itself; it is the pattern of cortisol dysregulation that results from chronic unresolved stress.
Understanding the actual physiology matters because the interventions that address cortisol dysregulation are specific and evidence-based, and different from the vague lifestyle suggestions most wellness content offers. It also matters for training: acute cortisol release is a normal and necessary part of the physiological response to exercise. Confusing acute adaptive cortisol with chronic dysregulation leads to mismanaged training and recovery.
Chronic psychological stress produces sustained HPA axis activation, elevated cortisol, suppressed immune function, impaired memory consolidation, disrupted sleep architecture, accelerated hippocampal atrophy, and increased visceral adiposity. These are not long-term theoretical risks, they are measurable changes in people under sustained occupational, relational, or financial stress. (McEwen BS, NEJM 1998; Chrousos GP, NEJM 1995)
In healthy adults, cortisol follows a predictable daily pattern: it peaks sharply within 30–45 minutes of waking (the cortisol awakening response, or CAR), remains relatively elevated through the morning, declines through the afternoon, and reaches its nadir around midnight. This rhythm is essential for metabolic regulation, immune function, cognitive performance, and sleep architecture. Chronic stress disrupts this pattern in measurable ways: the CAR is blunted or absent, daytime cortisol may be elevated or flattened, and night-time cortisol remains elevated when it should be at its lowest. Each of these disruptions has distinct physiological consequences. The diurnal pattern also explains why morning cortisol testing, not random or afternoon testing, is the clinically meaningful measurement.
Training implication: The cortisol awakening response serves a priming function, mobilising glucose and free fatty acids for the day ahead. Morning exercise aligns with the natural cortisol peak. This is not a reason to avoid evening training, but it does explain why morning training often feels more metabolically efficient.
The hypothalamic-pituitary-adrenal (HPA) axis regulates cortisol production through a feedback loop. Stress activates the hypothalamus, which releases CRH; this stimulates ACTH release from the pituitary; ACTH drives cortisol production in the adrenal cortex. Elevated cortisol feeds back to suppress CRH and ACTH, completing the loop. In healthy individuals, this system activates appropriately to stressors and then returns to baseline. In chronically stressed individuals, the negative feedback becomes impaired, either through receptor downregulation (producing elevated chronic cortisol) or through HPA exhaustion (producing abnormally low cortisol, seen in burnout and severe overtraining). Both patterns are measurable and both represent dysregulation, though they look opposite on a blood or saliva test.
The burnout pattern: Chronic stress does not always produce high cortisol. In burnout and advanced overtraining, the HPA axis may show blunted output, low morning cortisol, absent CAR, fatigue, cognitive impairment. This is sometimes misinterpreted as a normal state rather than a clinical one.
Exercise produces an acute cortisol spike proportional to intensity and duration. This is not harmful, it is necessary for mobilising energy, modulating inflammation, and supporting the physiological demands of training. The cortisol response to training normalises within hours of exercise completion in well-recovered athletes. In overtrained or chronically stressed individuals, the return to baseline is delayed or incomplete, compounding accumulated HPA dysregulation. The distinction between acute adaptive cortisol (from exercise, acute psychological stressors, acute illness) and chronic dysregulation (from sustained unresolved psychological, occupational, or physiological stress) is the essential one that most wellness content collapses. Managing them requires different approaches.
Training relevance: The acute cortisol spike from a hard training session is not a problem unless you are already in a state of accumulated HPA dysregulation. If you are, as evidenced by poor recovery, low mood, disrupted sleep, and declining performance, adding more training stress does not help.
The consequences of sustained cortisol elevation, described by McEwen as allostatic load, are extensive and well-documented. Chronic elevated cortisol promotes visceral fat deposition through glucocorticoid receptor activation in adipose tissue, suppresses immune function through inhibition of pro-inflammatory cytokines (making you more susceptible to infection), impairs memory and cognitive function through hippocampal atrophy, disrupts sleep architecture by suppressing slow-wave sleep, reduces testosterone and oestrogen through competitive inhibition of steroid hormone synthesis, and accelerates muscle protein breakdown through glucocorticoid-induced catabolism. These effects are dose and duration dependent, they are not the consequence of occasional stress, but of sustained unresolved stress over weeks, months, or years.
The visceral fat connection: Chronic cortisol elevation is a direct mechanism linking psychological stress to visceral adiposity, metabolic syndrome, and elevated cardiovascular risk. This is why waist-to-height ratio and WtHR often worsen during periods of sustained occupational or personal stress even without changes in diet.
Sleep is the primary biological context in which HPA axis downregulation and hormonal restoration occurs. Slow-wave sleep suppresses cortisol, promotes growth hormone release, and allows recovery of glucocorticoid receptor sensitivity. Chronic sleep restriction produces HPA dysregulation independently of external psychological stressors, even in the absence of obvious life stress, consistently poor or short sleep generates measurable cortisol abnormalities. This creates a self-reinforcing cycle: elevated cortisol disrupts sleep architecture (particularly slow-wave sleep), and disrupted sleep impairs the overnight HPA downregulation that would normalise cortisol. Addressing sleep quality is the first and highest-yield intervention for someone with signs of cortisol dysregulation.
Practical priority order: If cortisol dysregulation is suspected, address sleep first (see the Sleep resource), training load second, psychological stressors third, and supplementation (ashwagandha, phosphatidylserine) last. The latter have modest evidence; the former have strong evidence.
One of the most consistent findings in exercise and stress research is that regular moderate aerobic exercise reduces HPA reactivity to subsequent stressors, the cortisol response to a given psychological or physiological challenge is smaller in fit, regularly-exercising individuals than in sedentary ones. This is a genuine physiological adaptation: regular exercise downregulates glucocorticoid receptor sensitivity in the hippocampus and prefrontal cortex, improving negative feedback and reducing chronic HPA activation. Zone 2 training, specifically, operates at an intensity that produces beneficial HPA adaptation without generating the acute cortisol loads of high-intensity training, making it the most appropriate training modality for people in states of accumulated psychological stress.
Important caveat: High-volume high-intensity training in someone already experiencing chronic stress and HPA dysregulation is additive, not corrective. More training is not more recovery. In this situation, volume and intensity reduction combined with zone 2 work and sleep prioritisation is the correct approach.
Adaptogenic herbs, herbs purported to normalise the stress response, include ashwagandha (Withania somnifera), rhodiola rosea, and others. Ashwagandha has the most consistent evidence: a 2019 RCT found that 240mg daily of a standardised extract significantly reduced serum cortisol, perceived stress scores, and anxiety compared to placebo over 60 days. Multiple subsequent trials have replicated these findings. The effect size is modest (approximately 20–30% reduction in cortisol and perceived stress, and the mechanism is not fully understood. It is a reasonable adjunct for individuals dealing with high psychological stress who have already addressed sleep, exercise, and lifestyle factors. It is not a substitute for addressing the structural causes of chronic stress.
Evidence-based dosing: 300–600mg of root extract (KSM-66 or Sensoril standardised extracts are the most studied) daily, taken with food. Effects are gradual and typically apparent at 4–8 weeks. Well-tolerated; some individuals experience GI discomfort at higher doses.
Cortisol measurement is available through several modalities: blood (snapshot at time of test), urine (24-hour total output), and saliva (captures the diurnal pattern when measured at multiple points). Four-point salivary cortisol testing, measuring at waking, 30 minutes post-waking, midday, and evening, provides the most clinically useful picture of HPA axis function and diurnal rhythm disruption. This testing is not routinely available on the NHS unless adrenal disease is suspected, but is available through private functional medicine and sports medicine providers. For most people, proxy markers, HRV data, sleep quality, resting heart rate, subjective energy and mood patterns, and training performance trends, provide a sufficient practical picture of HPA function without formal testing.
HRV as a cortisol proxy: Elevated cortisol suppresses parasympathetic (vagal) tone, which directly reduces HRV. Persistently suppressed morning HRV in the absence of heavy training load is a consistent proxy indicator of HPA dysregulation. It is not diagnostic but it is practically useful.
The physiology is clear: the acute stress response is adaptive and necessary. The chronic, unresolved stress response, producing sustained HPA axis dysregulation, elevated cortisol, disrupted sleep, visceral adiposity, immune suppression, and cognitive impairment, is directly pathological. The difference between the two is resolution: acute stressors that resolve leave no lasting physiological impact; chronic stressors that do not resolve accumulate their consequences over time.
The interventions are ordered by evidence: sleep quality first, appropriate training load second, structural stress reduction third, supplementation fourth. Managing cortisol through supplements while ignoring sleep deprivation or consistently overtraining is the wrong order of operations. Address the fundamentals first.
Book The Benchmark →McEwen BS, Protective and damaging effects of stress mediators. NEJM 1998;338(3):171–179. The foundational paper on allostatic load and chronic stress pathophysiology.
Chrousos GP, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. NEJM 1995;332(20):1351–1362. HPA axis mechanisms in stress and inflammation.
Chandrasekhar K et al., A prospective, randomised double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 2012;34(3):255–262. The primary ashwagandha RCT.
Hellhammer DH, Wust S, Kudielka BM, Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009;34(2):163–171. Methodology for cortisol measurement and interpretation.
Sapolsky RM, Why Zebras Don't Get Ulcers (3rd ed). Henry Holt 2004. The definitive accessible account of chronic stress physiology, extensively referenced in the peer-reviewed literature.